These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 8133055)

  • 1. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
    van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer SJ; Hack CE; Aarden LA; ten Cate JW
    J Immunol; 1993 Aug; 151(4):2318-25. PubMed ID: 8345209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.
    van der Poll T; Jansen J; Levi M; ten Cate H; Hack CE; Aarden LA; ten Cate JW; van Deventer SJ
    Scand J Immunol; 1996 Jan; 43(1):122-5. PubMed ID: 8560191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; Hack CE; ten Cate H; van Deventer SJ; Eerenberg AJ; de Groot ER; Jansen J; Gallati H; Büller HR
    J Exp Med; 1994 Apr; 179(4):1253-9. PubMed ID: 8145042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
    J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs.
    Kawamura M; Kitayoshi T; Terashita Z; Fujiwara S; Takatani M; Nishikawa K
    J Lipid Mediat Cell Signal; 1994 May; 9(3):255-65. PubMed ID: 7921785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO; Letts G; Meade CJ
    J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
    Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
    Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
    Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
    J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose endotoxemia and human neuropsychological functions.
    Krabbe KS; Reichenberg A; Yirmiya R; Smed A; Pedersen BK; Bruunsgaard H
    Brain Behav Immun; 2005 Sep; 19(5):453-60. PubMed ID: 15963684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
    Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
    Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of TCV-309--a potent PAF antagonist.
    Terashita Z; Takatani M; Nishikawa K
    J Lipid Mediat; 1992; 5(2):183-5. PubMed ID: 1445598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.
    van der Poll T; Levi M; ten Cate H; Jansen J; Biemond BJ; Haagmans BL; Eerenberg A; van Deventer SJ; Hack CE; ten Cate JW
    Clin Exp Immunol; 1995 Apr; 100(1):21-5. PubMed ID: 7697917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.
    DeLa Cadena RA; Majluf-Cruz A; Stadnicki A; Tropea M; Reda D; Agosti JM; Colman RW; Suffredini AF
    Thromb Haemost; 1998 Jul; 80(1):114-8. PubMed ID: 9684796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermia induces IL-1 alpha but does not decrease release of IL-1 alpha or TNF-alpha after endotoxin.
    Blake D; Bessey P; Karl I; Nunnally I; Hotchkiss R
    Lymphokine Cytokine Res; 1994 Oct; 13(5):271-5. PubMed ID: 7858059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; van Deventer SJ; ten Cate H; Haagmans BL; Biemond BJ; Büller HR; Hack CE; ten Cate JW
    Blood; 1994 Jan; 83(2):446-51. PubMed ID: 8286742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.